PedAM
Pediatric Disease Annotations & Medicines
| Disease | hyperparathyroidism |
| Phenotype | C0035078|renal failure |
| Sentences | 24 |
| PubMedID- 20454761 | Supra-acetabular brown tumor due to primary hyperparathyroidism associated with chronic renal failure. |
| PubMedID- 25886405 | Hyperphosphatemia, hypocalcemia and hyperparathyroidism in children with chronic renal failure plays a significant role in bone disorders [1]. |
| PubMedID- 24644527 | In the third type, patients usually have a concurrent disease, such as chronic renal failure, with secondary hyperparathyroidism, hypervitaminosis d, milk-alkali syndrome, and bone destruction capable of causing soft-tissue calcification. |
| PubMedID- 25199318 | Methods: seven adult patients who had undergone parathyroidectomy for secondary hyperparathyroidism associated with chronic renal failure were included in this study. |
| PubMedID- 23185261 | Although transplantation can resolve many biochemical imbalances, such as hyperparathyroidism, associated with chronic renal failure, progressive loss of bmd in the trabecular bone often occurs early after renal transplantation [3]. |
| PubMedID- 24795828 | Hypercalcemia and hyperparathyroidism resulting from chronic renal failure cause soft tissue microcalcification [14]. |
| PubMedID- 21168373 | Vitamin d therapy is widely used for the treatment of hyperparathyroidism associated with chronic renal failure in renal disease patients. |
| PubMedID- 22101574 | Secondary and tertiary hyperparathyroidism (hpt) develop in patients with renal failure due to a variety of mechanisms including increased phosphorus and fibroblast growth factor 23 (fgf23), and decreased calcium and 1,25-dihydroxy vitamin d levels. |
| PubMedID- 25130159 | Brown tumors may occur secondary to hyperparathyroidism in patients with chronic renal failure (ckd). |
| PubMedID- 21112268 | [surgical treatment of secondary hyperparathyroidism in patients with chronic renal failure]. |
| PubMedID- 22482374 | Subjects on therapy like vitamin d and calcium supplements, corticosteroids or anti-epileptic medicines, primary hyperparathyroidism and hypercalcaemia, with co-morbidity like renal failure, liver disease and history of malabsorption, diarrhea or hyperthyroidism were excluded. |
| PubMedID- 22009809 | The diagnostic accuracy of high resolution ultrasound imaging for detection of secondary hyperparathyroidism in patients with chronic renal failure. |
| PubMedID- 25988877 | The cost-effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence regarding paricalcitol and cinacalcet. |
| PubMedID- 20844668 | (3) secondary tumoral calcinosis: (chronic renal failure with secondary hyperparathyroidism, hypervitaminosis d, milk-alkali syndrome, and bone destruction). |
| PubMedID- 21876786 | Hyperphosphatemia is a driving force in the pathogenesis of vascular calcification (vc) and secondary hyperparathyroidism associated with renal failure. |
| PubMedID- 26321566 | The second patient had end-stage renal failure with tertiary hyperparathyroidism and was on haemodialysis. |
| PubMedID- 24959180 | Cinacalcet (sensipar), a calcimimetic drug, is available for the treatment of secondary hyperparathyroidism associated with renal failure, hypercalcemia in parathyroid cancer, and the treatment of severe hypercalcemia in patients with primary hyperparathyroidism unable to undergo parathyroidectomy [17–19]. |
| PubMedID- 20800255 | Background: in multiple endocrine neoplasia type i and renal failure, the type of initial parathyroidectomy for hyperparathyroidism may influence the operative risks and development of recurrence. |
| PubMedID- 22348675 | [primary hyperparathyroidism as a cause of chronic renal failure]. |
| PubMedID- 26134532 | Comparison between subtotal parathyroidectomy and total parathyroidectomy with autotransplantation for secondary hyperparathyroidism in patients with chronic renal failure: a meta-analysis. |
| PubMedID- 21655171 | [45] hyperparathyroidism in renal failure is the result of retention of phosphate due to decreased glomerular filtration rate, with consequent hypocalcemia resulting in parathyroid gland stimulation. |
| PubMedID- 22984610 | Calcitriol is an fda-approved drug commonly indicated in the management of secondary hyperparathyroidism in patients with renal failure, whereas astemizole was withdrawn from u.s. and european markets in 1999 after concerns about the drug's safety. |
| PubMedID- 21030332 | The extensive myocardial calcification was secondary to hyperparathyroidism with renal failure. |
| PubMedID- 24261327 | Primary hyperparathyroidism with chronic renal failure in a vietnamese pot-bellied pig (sus scrofa). |
Page: 1